Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …

Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …

Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …

Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …

Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …

NeuropeptideYgene therapy decreases chronic spontaneous seizures in a rat model of
temporal lobe epilepsy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …

Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …

Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of
temporal lobe epilepsy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Temporal lobe epilepsy remains amongst the most common and drug refractory of
neurological disorders. Gene therapy may provide a realistic therapeutic approach …